RELMADA THERAPEUTICS, INC.

A clinical-stage biotech developing novel therapies for CNS diseases and oncology.

RLMD | NDAQ

Overview

Corporate Details

ISIN(s):: US75954H1005 (+1 more)
LEI:
Country:: United States of America
Address:: 2222 PONCE DE LEON BLVD. 3RD FLOOR, 33134 CORAL GABLES
Website:: https://www.relmada.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative and novel treatments for debilitating disorders. The company's primary research area is central nervous system (CNS) diseases, with a significant focus on therapies for major depressive disorder (MDD), including its lead candidate esmethadone. Relmada is also advancing its development pipeline into oncology, with programs such as NDV-01 for urologic cancers. The company's mission is to create transformative medicines that improve human health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:00	Regulatory News Service 8-K - RELMADA THERAPEUTICS, INC. (0001553643) (Filer)	English	34.7 MB

Automate Your Workflow. Get a real-time feed of all RELMADA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RELMADA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RELMADA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Soiken Holdings Inc. A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.	Japan	2385
Sotkamo Silver AB Mines silver, gold, and zinc in Finland to supply essential metals for green technologies.	Sweden	SOSI
Stagwell Inc A digital-first marketing network transforming brands with data, media, and creative services.	United States of America	STGW
Star Equity Holdings, Inc. A diversified holding co. in building, talent solutions, energy services, and investments.	United States of America	STRR
Stem Cells Spin Spolka Akcyjna Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.	Poland	SCS
STRANGER HOLDINGS PLC Mining and developing uranium and strategic metals with near-term production projects in Africa.	United Kingdom	STHP
Ströer SE & Co. KGaA A media company providing integrated out-of-home (OOH) and digital advertising solutions.	Germany	SAX
STUDIO ALICE Co.,Ltd. Specialized photo studios capturing family milestones with costumes, styling, and kimono rentals.	Japan	2305
Surrozen, Inc./DE Develops regenerative antibodies modulating the Wnt pathway to repair tissues and restore organs.	United States of America	SRZN
SUSMED, Inc. Develops digital therapeutics (DTx) and AI systems to streamline clinical development.	Japan	4263